Current neurocognitive pen and paper assessments lack the precision to detect minor changes in cognition and to accurately monitor them over time. Diagnostic procedures such as imaging and lumbar punctures are expensive and invasive. ViewMind can make neurodegenerative disease diagnosis accessible to more patients, earlier than ever.